Glooko has been recognized as the top MedTech software provider in the 2026 MedTech Breakthrough Awards, highlighting its significant contributions to diabetes management.
Based in Palo Alto, Glooko, Inc. specializes in digital health solutions aimed at improving diabetes care and glycemic safety. The company’s diabetes management platform, along with its EndoTool® Glucose software, has been pivotal in addressing the complexities of diabetes management in clinical settings. This award marks a notable achievement in the MedTech industry, reflecting Glooko's commitment to enhancing patient outcomes through innovative technology.
The recognition at the MedTech Breakthrough Awards underscores the increasing importance of digital health tools in managing chronic conditions like diabetes. As healthcare continues to evolve, solutions that integrate technology with clinical practice are becoming essential for effective patient care.
Moving forward, Glooko's award may serve as a catalyst for further advancements in the digital health space, encouraging other companies to innovate and improve their offerings for better patient management and outcomes in chronic disease care.